SG
SpyGlass Pharma, Inc. Common Stock
SGP · NASDAQ
$29.08 -0.58% (-$0.17)
1M +10.74%
Market Cap $972.2M
P/E Ratio -
Div. Yield -
ROE 75.64%
Valuation
48 /100
Fair P/B 4.18x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 26.54%
ROE 75.64%
ROA 23.03%
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 25.06x
Int. coverage N/A
Stability
50 /100
Moderate Beta -0.93x
Rev. volatility N/A
EPS volatility N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SGP
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Patrick H. Mooney
Employees
76
Headquarters
Irvine
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report